Equities

Medexus Pharmaceuticals Inc

Medexus Pharmaceuticals Inc

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (CAD)2.01
  • Today's Change-0.02 / -0.99%
  • Shares traded79.71k
  • 1 Year change+11.67%
  • Beta1.9009
Data delayed at least 15 minutes, as of Nov 14 2024 20:58 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Medexus Pharmaceuticals Inc. is a Canada-based specialty pharmaceutical company with a North American commercial platform. The Company has a portfolio of rare disease treatment solutions. Its focus is on the therapeutic areas of oncology, hematology, rheumatology, autoimmune diseases, allergy, and dermatology. It operates through two segments: Medexus Pharma Canada and Medexus Pharma USA. Its lead products are IXINITY (US), Rupall (Canada), Rasuvo (US) and Metoject (Canada), and Gleolan (US). IXINITY (US) is an intravenous recombinant factor IX therapeutic for use in patients with hemophilia B. Rupall (Canada) is a prescription allergy medication with a mode of action. Rasuvo (US) and Metoject (Canada) is a formulation of methotrexate designed to treat rheumatoid arthritis and other autoimmune diseases. Gleolan (US) is an optical imaging agent indicated in patients with glioma as an adjunct for the visualization of malignant tissue during surgery.

  • Revenue in CAD (TTM)147.26m
  • Net income in CAD3.23m
  • Incorporated2021
  • Employees98.00
  • Location
    Medexus Pharmaceuticals Inc10 King Street East, Suite 600TORONTO M5C 1C3CanadaCAN
  • Phone+1 (514) 762-2626
  • Websitehttps://www.medexus.com/en_US
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Medipharm Labs Corp37.76m-13.49m28.77m166.00--0.6043--0.7621-0.0378-0.03780.10330.11580.56622.753.82227,451.80-20.22-32.88-24.86-39.5623.80-5.88-35.72-67.662.33--0.0557--49.4926.5256.37---49.66--
Charlotte's Web Holdings Inc76.68m-62.44m29.92m164.00--0.5942--0.3902-0.4046-0.40460.49590.31980.35611.3425.09467,583.80-29.00-25.71-33.48-29.0348.0748.98-81.43-63.112.07-42.570.5481---14.82-1.9059.88---7.88--
Decibel Cannabis Company Inc101.04m-563.00k30.98m----0.66479.430.3066-0.0016-0.00960.23490.10530.75551.646.86---0.421-3.55-0.6781-5.1926.7015.77-0.5572-7.130.3644-3.030.5178--46.18--60.33---32.45--
Medicus Pharma Ltd0.00-16.49m35.25m----3.89-----3.58-3.580.000.83610.00-------267.24-652.37-371.17-------------20.260.0549-------300.86------
Medexus Pharmaceuticals Inc147.26m3.23m50.04m98.0015.431.094.350.33980.13160.13166.031.870.67251.585.87--1.47-5.032.98-7.7752.4653.262.19-8.050.41031.970.5676--4.5934.37-117.53---9.45--
LSL Pharma Group Inc14.32m-2.03m50.26m----2.50--3.51-0.0232-0.02320.16120.17430.43072.286.06---6.12---8.70--22.68---14.20--0.4909-0.37220.4126--------------
Auxly Cannabis Group Inc114.61m-74.79m51.38m369.00--0.4608--0.4483-0.0754-0.07540.09810.08680.40282.485.95310,601.60-26.28-21.47-38.58-24.9918.535.08-65.26-124.150.4801-1.190.3913--6.99166.8565.84---40.92--
Simply Solventless Concentrates Ltd-100.00bn-100.00bn54.13m----4.41----------0.1293------------------------0.1873--0.2432--------------
Simply Better Brands Corp74.11m-33.98m59.08m--------0.7972-0.4554-0.26470.9969-0.01622.136.1226.56---91.16-63.90-324.18-215.4850.71---42.73-29.460.3868-1.021.33--22.08---96.41------
Eastwood Bio-Medical Canada Inc653.54k-484.16k68.89m--------105.40-0.007-0.0070.0095-0.01661.60--21.00---118.87-52.23---140.2962.2852.09-74.08-52.90---63.73-----33.223.13-264.69------
Data as of Nov 14 2024. Currency figures normalised to Medexus Pharmaceuticals Inc's reporting currency: Canadian Dollar CAD
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.